search icon
      blog search icon

      CBIO Stock Price History and Quote Analysis: Insights for Investors

      Catalyst Biosciences, Inc.

      (NASDAQ:CBIO)

      $0.51

      -0.01 (-2.67%)

      Open: 1:36 PM

      CBIO Stock Price Graph

      • 1D
      • 5D
      • 1M
      • 3M
      • 6M
      • 1Y
      • YTD
      • All

      CBIO Stock Price Today

      Catalyst Biosciences, Inc. (CBIO) stock declined over -96.66% intraday to trade at $0.5113 a share on NASDAQ. The stock opened with a loss of -96.29% at $0.57 and touched an intraday high of $0.58, falling -96.66% against the last close of $15.29. The Catalyst Biosciences, Inc. in stock market went to a low of $0.48 during the session.

      CBIO Stock Snapshot

      $15.29

      Prev. Close

      1.22 Billion

      Market Cap

      $0.48

      Day Low

      $0.57

      Open

      N/A

      Number of Shares

      $0.58

      Day High

      N/A

      P/E ratio

      -17.57

      EPS (TTM)

      N/A

      Cash Flow per Share

      N/A

      Free Float in %

      N/A

      Book Value

      461K

      Volume

      CBIO Stock Price History Chart

      DateOpenHighLowCloseVolume

      Contact Details

      611 Gateway Boulevard
      South San Francisco, CA 94080
      US

      Website:https://www.catalystbiosciences.com

      Contact #:650 871 0761

      Company Information

      EmployeesN/A

      BetaN/A

      Sales or RevenueN/A

      5Y Sales ChangeN/A

      Fiscal Year EndsN/A

      SectorHealthcare

      IndustryBiotechnology

      About Company

      Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD); and CB 4332 for patients with deficiencies in complement factor I (CFI), including dAMD. The company also develops ProTUNE C3b/C4b degrader and ImmunoTUNE C3a/C5a degrader platforms designed to target other disorders of the complement or inflammatory pathways. It has a strategic research collaboration with Mosaic Biosciences, Inc.; and license and collaboration agreement with Biogen International GmbH. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California.

      Peers

      Frequently Asked Questions

      icon

      What is the current Catalyst Biosciences, Inc. (CBIO) stock price?

      Catalyst Biosciences, Inc. (NASDAQ: CBIO) stock price is $0.51 in the last trading session. During the trading session, CBIO stock reached the peak price of $0.58 while $0.48 was the lowest point it dropped to. The percentage change in CBIO stock occurred in the recent session was -96.66% while the dollar amount for the price change in CBIO stock was -$14.78.

      icon

      CBIO's industry and sector of operation?

      The NASDAQ listed CBIO is part of Biotechnology industry that operates in the broader Healthcare sector. Catalyst Biosciences, Inc. , a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation.

      icon

      Who are the executives of CBIO?

      Dr. Grant Blouse M.Sc., Ph.D.
      Chief Scientific Officer
      Ms. Ana Kapor
      Senior Director of Investor Relations & Corporation Communications
      Dr. Tom Knudsen D.V.M., Ph.D.
      Senior Vice President of Corporation Devel.
      Ms. Seline E. Miller CPA
      Senior Vice President of Fin., Interim Chief Financial & Principal Accounting Officer

      icon

      How CBIO did perform over past 52-week?

      CBIO's closing price is 0.13% higher than its 52-week low of $0.1887 where as its distance from 52-week high of $8.693999 is -0.90%.

      icon

      How many employees does CBIO have?

      Number of CBIO employees currently stands at N/A. CBIO operates from 611 Gateway Boulevard, South San Francisco, CA 94080, US.

      icon

      Link for CBIO official website?

      Official Website of CBIO is: https://www.catalystbiosciences.com

      icon

      How do I contact CBIO?

      CBIO could be contacted at phone #650 871 0761 and can also be accessed through its website. CBIO operates from 611 Gateway Boulevard, South San Francisco, CA 94080, US.

      icon

      How many shares of CBIO are traded daily?

      CBIO stock volume for the day was 460710.00 shares. The average number of CBIO shares traded daily for last 3 months was 69.46 Thousands.

      icon

      What is the market cap of CBIO currently?

      The market value of CBIO currently stands at $1.22 Billion with its latest stock price at $0.51 and N/A of its shares outstanding.